LSBWF · LakeShore Biopharma Co., Ltd.
$0.01
-0.06 (-92.54%)
At close · Jul 6
Market Cap
$2.76M
Shares
41.21M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W$0.01–1.48
Avg vol 30d10K
Short int1K · 0.0% float · 1000.0d
Short vol100%
DataMar 2023–Jul 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−99%
below
Price vs 50-day avg
−91%
below
RSI (14)
18
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−94%
trailing
6-month return
−99%
trailing
YTD return
−99%
this year
Relative strength
−108%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Squeeze score
14
low risk · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
Gross margin
82%
expanding
EPS growth
+87%
Y/Y
Free cash flow
$-18.6M
Balance sheet
$22.4M
net cash
Quant / Vol
risk profile
Volatility
220%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
272.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−99%
Bearish
Price vs 50-day avg
−91%
Bearish
RSI (14)
18
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $1
vs 200-day avg -99%
vs 50-day avg -91%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LSBWF
this stock
LakeShore Biopharma Co., Ltd.
|
$2.76M | -99.4% | +6.0% | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$460.58B | +4.9% | +22179.2% | 937.3 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.33B | +6.3% | +46.2% | 28.6 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.79B | -12.4% | +20.8% | 16.5 | 3.3% |
|
ARGX
Argenx SE
|
$54.72B | +4.0% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
1
- % held
- 0.1%
- Net QoQ
- -298.7K sh
- Top holder
- BARCLAYS PLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LSBWF | -92.5% | -93.8% | -99.4% | -92.5% | -99.4% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | -95.6% | -93.0% | -107.7% | -93.1% | -109.6% |